Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Plos One|December 17, 2013
Differential gene expression of cardiac ion channels in human dilated cardiomyopathyMaria Micaela Molina-Navarro, Esther Roselló-Lletí, Ana Ortega, et al.
Computational and Structural Biotechnology Journal|March 8, 2021
Biochemical and Structural Characterization of a novel thermophilic esterase EstD11 provide catalytic insights for the HSL familyVega Miguel-Ruano, Ivanna Rivera, Jelena Rajkovic, et al.
Frontiers in Pharmacology|February 21, 2022
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective ProfileAlana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, et al.
Biochemical Pharmacology|October 25, 2019
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty ratsAlana Aragón-Herrera, Sandra Feijóo-Bandín, Manuel Otero Santiago, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2023
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty ratsAlana Aragón-Herrera, Sandra Moraña-Fernández, Manuel Otero-Santiago, et al.
Biochemical Pharmacology|October 18, 2024
Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fractionSandra Moraña-Fernández, Xocas Vázquez-Abuín, Alana Aragón-Herrera, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 12, 2025
Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fractionXocas Vázquez-Abuín, Sandra Moraña-Fernández, Alana Aragón-Herrera, et al.
Pageof 5